XML 56 R32.htm IDEA: XBRL DOCUMENT v3.25.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2024
Income Tax Disclosure [Abstract]  
Schedule of IncomeTax Expense

Income tax expense for the years ended December 31, 2024 and 2023 consists of the following:

 

 

As of December 31,

 

 

 

2024

 

 

2023

 

 

U.S. federal

 

 

 

 

 

 

 

Current

 

$

(718,582

)

 

$

718,582

 

 

Deferred

 

 

-

 

 

 

-

 

 

Total U.S. federal

 

 

(718,582

)

 

 

718,582

 

 

State and local

 

 

 

 

 

 

 

Current

 

 

(1,705

)

 

 

5,270

 

 

Deferred

 

 

-

 

 

 

-

 

 

Total State and local

 

 

(1,705

)

 

 

5,270

 

 

Income tax expense

 

$

(720,287

)

 

$

723,852

 

 

 

 

 

 

 

 

 

 

Summary of Reconciliation of Income Tax Benefit at the Statutory Federal Income Tax Rate and Income Taxes

A reconciliation of income tax benefit at the statutory federal income tax rate and income taxes as reflected in the financial statements is as follows:

 

 

 

As of December 31,

 

 

Rate reconciliation:

 

2024

 

 

 

2023

 

 

Federal tax benefit at statutory rate

 

 

(21.0

)

%

 

 

(21.0

)

%

Permanent differences

 

 

0.6

 

 

 

 

0.2

 

State income tax

 

 

(0.1

)

 

 

 

(0.1

)

 

Research and development credits

 

 

(2.9

)

 

 

 

(2.9

)

 

Change in tax rate

 

 

0.0

 

 

 

 

(0.2

)

 

Change in valuation allowance

 

 

16.0

 

 

 

 

34.2

 

Other

 

 

2.7

 

 

 

 

(0.1

)

Total provision

 

 

(4.7

)

%

 

 

10.10

 

%

Components of Deferred Tax Assets

Significant components of the Company's deferred tax assets consisted of the following:

 

 

As of December 31,

 

Deferred tax assets

 

2024

 

 

2023

 

Startup costs

 

$

1,673,301

 

 

$

2,945,099

 

Section 174 capitalization

 

 

3,641,638

 

 

 

1,860,806

 

Share-based compensation

 

 

462,487

 

 

 

144,105

 

Net operating losses

 

 

1,351,896

 

 

 

439,349

 

Accrued expenses and other

 

 

222,198

 

 

 

45,133

 

Capitalized license fees

 

 

41,981

 

 

 

47,526

 

Credit carryforwards

 

 

489,284

 

 

 

30,035

 

Deferred revenue

 

 

250,363

 

 

 

121,388

 

Fixed assets

 

 

(4,074

)

 

 

(8,325

)

Valuation allowance

 

 

(8,129,074

)

 

 

(5,625,116

)

Deferred tax assets, net of valuation allowance

 

$

-

 

 

$

-